Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system
Patent
1993-08-30
1999-10-12
Bernhardt, Emily
Organic compounds -- part of the class 532-570 series
Organic compounds
Four or more ring nitrogens in the bicyclo ring system
544239, 544240, 544241, C07D23720
Patent
active
059657324
ABSTRACT:
Compounds of the formula ##STR1## inhibit endothelin, wherein: R is phenyl, naphthyl or biphenyl, each of which may be substituted.
REFERENCES:
patent: 2524802 (1950-10-01), Hultquist et al.
patent: 2542856 (1951-02-01), Wright et al.
patent: 2888455 (1959-05-01), Kano et al.
patent: 3055886 (1962-09-01), Goodemoot et al.
patent: 4415496 (1983-11-01), Harris et al.
patent: 4661479 (1987-04-01), Wyvratt, Jr. et al.
patent: 5464853 (1995-11-01), Chan et al.
patent: 5514691 (1996-05-01), Chan et al.
patent: 5514696 (1996-05-01), Murugesan et al.
patent: 5571821 (1996-11-01), Chan et al.
Stein, P.D. et al., The Discovery of Sulfonamide Endothelin Antagonists and the Development of the Orally Active ET(A) Antagonist 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide, J. of Medicinal Chemistry, vol. 37, No. 3 (1994) pp. 329-331.
Chan, M.F. et al., Identification of a New Class of ET(A) Selective Endothelin Antagonists by Pharmacophore Directed Screening, Biochemical and Biophysical Research Comm., vol. 201, No. 1 (1994) pp.228-234.
Heinisch, G. et al., Pharmacologically Active Pyridazine Derivatives. Part 1, Progress In Medicinal Chemistry, vol. 27 (1990) pp. 2-49.
Kruger, T. E. et al., Die Antibakterielle Wirkung Des Nicht Eiweissgebundenen Anteils Der Sulfanilamide Im Menschlichen Plasmawasser, Arzneimittel-Forschung, vol. 15, No. 11, (1965) pp. 1390-1317.
Doherty, A.M., Endothelin: A New Challenge, J. of Medicinal Chemistry, vol. 35, No. 9 (1992) pp. 1493-1508.
Becker et al, Chemical Abstracts, vol. 75, No. 49119 (1971).
Naito et al, Chemical Abstracts, vol. 68, No. 114622 (1968).
Mihara et al, European Journal of Pharmacology, 246, pp. 33-38, 1993.
Clozel et al, Nature, 365, pp. 759-761 (1993).
Derwent Abstract No. 88-289069/41 Feb. 27, 1987 (Abstract for JP63/211271).
Derwent Abstract No. 88-195835/28 Nov. 26, 1986 (Abstract for JP63/135368).
Derwent Abstract No. 88-061295/09 Jul. 9, 1986 (Abstract for JP63/017870).
Derwent Abstract No. 87-152485/22 Oct. 11, 1985 (Abstract for JP62/087581).
Derwent Abstract No. 62299 E/30 Dec. 11, 1980 (Abstract for JP57/098253).
Derwent Abstract No. 40927 D/23 Sep. 11, 1979 (Abstract for JP56/040660).
Derwent Abstract No. 91-254550/35 Feb. 19, 1990 (Abstract for EP 443983).
Derwent Abstract No. 86-246709/38 Nov. 27, 1985 (Abstract for EP 194548).
Derwent Abstract No. 35012 K/15 Sep. 24, 1981 (Abstract for EP 76072).
Allen et al., "Preparation . . . antagonists", CA116(11):106284Z, p. 778, 1992.
R.D. Desai et al., Chemical Abstracts, vol. 71, No. 11, (1969) 49825c.
R.D. Desai et al., Chemical Abstracts, vol. 71, No. 3, (1969) 12872q.
S. Norio et al., Chemical Abstracts, vol. 70, No. 19, (1969) 87639g.
T. Saito, Chemical Abstracts, vol. 73, No. 23, (1970) 120511w.
Babajko Suzanne E.
Bernhardt Emily
Bristol-Myers Squibb Co.
Hermenau Ronald S.
Kilcoyne John M.
LandOfFree
Sulfonamide endothelin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonamide endothelin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonamide endothelin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-654101